QYLD vs RSP
Global X Nasdaq 100 Covered Call ETF vs Invesco S&P 500 Equal Weight ETF
- • RSP has the lower expense ratio at 0.20% vs 0.60% for QYLD.
- • QYLD pays a higher dividend yield (5.97%).
Side-by-side metrics
| Metric | QYLD | RSP |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.60% | 0.20% |
Dividend yield Trailing 12-month yield. | 5.97% | 1.46% |
AUM Assets under management — bigger funds are typically more liquid. | $8.20B | $100.66B |
YTD return | 10.56% | 16.71% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.47 | 0.80 |
P/E ratio | 28.74 | 20.31 |
Last price | $18.06 | $222.50 |
Inception | — | — |
Issuer | Global X | Invesco |
QYLD top holdings
| AAPL | Apple Inc | 8.24% |
| NVDA | NVIDIA Corp | 8.08% |
| MSFT | Microsoft Corp | 6.35% |
| MU | Micron Technology Inc | 4.52% |
| AMZN | Amazon.com Inc | 4.25% |
| AMD | Advanced Micro Devices Inc | 3.73% |
| TSLA | Tesla Inc | 3.44% |
| META | Meta Platforms Inc Class A | 3.00% |
| WMT | Walmart Inc | 2.72% |
| GOOGL | Alphabet Inc Class A | 2.69% |
RSP top holdings
| MRNA | Moderna Inc | 0.32% |
| PTC | PTC Inc | 0.30% |
| ACN | Accenture PLC Class A | 0.29% |
| IT | Gartner Inc | 0.26% |
| HAS | Hasbro Inc | 0.26% |
| P | Everpure Inc Class A | 0.26% |
| MTD | Mettler-Toledo International Inc | 0.25% |
| CRL | Charles River Laboratories International Inc | 0.25% |
| CCL | Carnival Corporation Ltd | 0.25% |
| RVTY | Revvity Inc | 0.25% |
About QYLD
QYLD (Global X Nasdaq 100 Covered Call ETF) is Nasdaq-100 covered call income strategy. Managed by Global X, the fund carries $8.2B in assets under management, an expense ratio of 0.60%, a dividend yield of 5.97%. Its largest holding is Apple Inc (AAPL), which represents 8.2% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 11.0%.
About RSP
RSP (Invesco S&P 500 Equal Weight ETF) is S&P 500 with each stock equally weighted. Managed by Invesco, the fund carries $100.7B in assets under management, an expense ratio of 0.20%, a dividend yield of 1.46%. Its largest holding is Moderna Inc (MRNA), which represents 0.3% of the portfolio. Real Estate is the fund's largest sector exposure at 5.8%.